Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 6

See more details

Referenced in 1 policy sources
Referenced in 1 patents
71 readers on Mendeley
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI118968

Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription.

S R Price, J L Bailey, X Wang, C Jurkovitz, B K England, X Ding, L S Phillips, and W E Mitch

Renal Division, Emory University School of Medicine, Atlanta, Georgia 30322, USA. medrp@emory.edu

Find articles by Price, S. in: PubMed | Google Scholar

Renal Division, Emory University School of Medicine, Atlanta, Georgia 30322, USA. medrp@emory.edu

Find articles by Bailey, J. in: PubMed | Google Scholar

Renal Division, Emory University School of Medicine, Atlanta, Georgia 30322, USA. medrp@emory.edu

Find articles by Wang, X. in: PubMed | Google Scholar

Renal Division, Emory University School of Medicine, Atlanta, Georgia 30322, USA. medrp@emory.edu

Find articles by Jurkovitz, C. in: PubMed | Google Scholar

Renal Division, Emory University School of Medicine, Atlanta, Georgia 30322, USA. medrp@emory.edu

Find articles by England, B. in: PubMed | Google Scholar

Renal Division, Emory University School of Medicine, Atlanta, Georgia 30322, USA. medrp@emory.edu

Find articles by Ding, X. in: PubMed | Google Scholar

Renal Division, Emory University School of Medicine, Atlanta, Georgia 30322, USA. medrp@emory.edu

Find articles by Phillips, L. in: PubMed | Google Scholar

Renal Division, Emory University School of Medicine, Atlanta, Georgia 30322, USA. medrp@emory.edu

Find articles by Mitch, W. in: PubMed | Google Scholar

Published October 15, 1996 - More info

Published in Volume 98, Issue 8 on October 15, 1996
J Clin Invest. 1996;98(8):1703–1708. https://doi.org/10.1172/JCI118968.
© 1996 The American Society for Clinical Investigation
Published October 15, 1996 - Version history
View PDF
Abstract

In normal subjects and diabetic patients, insulin suppresses whole body proteolysis suggesting that the loss of lean body mass and muscle wasting in insulinopenia is related to increased muscle protein degradation. To document how insulinopenia affects organ weights and to identify the pathway for accelerated proteolysis in muscle, streptozotocin-treated and vehicle-injected, pair-fed control rats were studied. The weights of liver, adipose tissue, and muscle were decreased while muscle protein degradation was increased 75% by insulinopenia. This proteolytic response was not eliminated by blocking lysosomal function and calcium-dependent proteases at 7 or 3 d after streptozotocin. When ATP synthesis in muscle was inhibited, the rates of proteolysis were reduced to the same level in insulinopenic and control rats suggesting that the ATP-dependent, ubiquitin-proteasome pathway is activated. Additional evidence for activation of this pathway in muscle includes: (a) an inhibitor of proteasome activity eliminated the increased protein degradation; (b) mRNAs encoding ubiquitin and proteasome subunits were increased two- to threefold; and (c) there was increased transcription of the ubiquitin gene. We conclude that the mechanism for muscle protein wasting in insulinopenia includes activation of the ubiquitin-proteasome pathway with increased expression of the ubiquitin gene.

Version history
  • Version 1 (October 15, 1996): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 6
  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 policy sources
Referenced in 1 patents
71 readers on Mendeley
See more details